The Lobby Jobs
  • Join The Lobby Medical Sales Network
  • Sign in
  • Sign up
  • Join The Lobby Medical Sales Network

2 jobs found in Columbus, OH

Refine Search
Current Search
Executive Columbus, OH
Search within
50 miles
10 miles 20 miles 50 miles 100 miles 200 miles
Refine by Categories
Sales  (25) Healthcare  (18) Management  (8) Marketing  (4) Customer Service  (2) Science  (2)
Information Technology  (1) Pharmaceutical  (1) Sports  (1)
More
Sanofi
May 26, 2026
Rare Blood Disorder - CABLIVI Institutional Account Director (IAD), Ohio/PA West
Sanofi Columbus, OH
Job title:  Rare Blood Disorder - CABLIVI Institutional Account Director (IAD), Ohio/PA West Location: Ohio or Pennsylvania W About the Job Sanofi is rapidly building momentum with the execution of its Rare Blood Disorders strategy, with an area of focus in acquired thrombotic thrombocytopenic purpura (ATTP) and CABLIVI (Caplacizumab-yhdp). Given the need for a true focus on the total account approach and execution, the organization has decided to develop an Institutional Account Director organization to further support and accelerate our CABLIVI initiatives. The CABLIVI Institutional Account Director (IAD) acts as the designated point of contact representing Sanofi to optimize access and pull through at high potential hospitals and health system/IDN accounts. CABLIVI IADs will be critical in serving evolving customer needs by providing a coordinated approach to achieve key goals at both the brand and above-brand level.   This individual will work closely and...
Madrigal Pharmaceuticals
Jun 02, 2026
Senior Director, Access & Reimbursement
Madrigal Pharmaceuticals OH
Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH.   Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c).   Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration. To...
  • Home
  • Contact
  • About Us
  • Terms & Conditions
  • Employer
  • Post a Job
  • Search Resumes
  • Sign in
  • Job Seeker
  • Find Jobs
  • Create Resume
  • Sign in
  • Facebook
  • Instagram
  • LinkedIn
© 2026 The Lobby Jobs - Medical Sales Job Marketplace